A simple device developed in Israel will spare patients the need for invasive, expensive and dangerous open-heart surgery.
Cuspa Medical has developed an artificial cusp that attaches to the heart valve – which opens and closes to let blood flow from one area of the heart to another, and in the right direction.
Typical treatment options for valvular heart disease — when a person’s heart valves can no longer open or close completely — include medication, surgery to repair the valve, or surgery to replace the valve, all of which are two invasive procedures with long rehabilitation times.
Cuspa’s simple device – known as Cusper – reduces backflow of blood to the heart chamber.
The artificial cusp is attached to the heart valve with a metal clip. Unlike open-heart surgery, the procedure is minimally invasive, using a catheter through the groin.
The device is pushed out of the sheath and directed to the desired location. It grabs the valve and holds it open to the original size, and when the valve closes, the device makes sure there is no gap and prevents leakage.
The Cusper is currently being tested for safety and effectiveness in large animals. It has two international patents pending approval in North America, Europe and Asia.
When a person’s heart valves are damaged or diseased, there is not enough blood that can be pushed through the heart to the rest of the body, and it returns to the chamber it came from.
If left untreated, patients will suffer from symptoms such as chest pain, fatigue, shortness of breath, and ultimately heart failure.
Cuspa Medical was founded in 2019 and is headquartered in Nazareth, Israel.